Literature DB >> 20033988

A sodium channel gene SCN9A polymorphism that increases nociceptor excitability.

Mark Estacion1, T Patrick Harty, Jin-Sung Choi, Lynda Tyrrell, Sulayman D Dib-Hajj, Stephen G Waxman.   

Abstract

Sodium channel Na(V)1.7, encoded by the SCN9A gene, is preferentially expressed in nociceptive primary sensory neurons, where it amplifies small depolarizations. In studies on a family with inherited erythromelalgia associated with Na(V)1.7 gain-of-function mutation A863P, we identified a nonsynonymous single-nucleotide polymorphism within SCN9A in the affected proband and several unaffected family members; this polymorphism (c. 3448C&T, Single Nucleotide Polymorphisms database rs6746030, which produces the amino acid substitution R1150W in human Na(V)1.7 [hNa(V)1.7]) is present in 1.1 to 12.7% of control chromosomes, depending on ethnicity. In this study, we examined the effect of the R1150W substitution on function of the hNa(V)1.7 channel, and on the firing of dorsal root ganglion (DRG) neurons in which this channel is normally expressed. We show that this polymorphism depolarizes activation (7.9-11mV in different assays). Current-clamp analysis shows that the 1150W allele depolarizes (6mV) resting membrane potential and increases ( approximately 2-fold) the firing frequency in response to depolarization in DRG neurons in which it is present. Our results suggest that polymorphisms in the Na(V)1.7 channel may influence susceptibility to pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033988     DOI: 10.1002/ana.21895

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

1.  A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia.

Authors:  Gilberto Vargas-Alarcon; Edith Alvarez-Leon; Jose-Manuel Fragoso; Angelica Vargas; Aline Martinez; Maite Vallejo; Manuel Martinez-Lavin
Journal:  BMC Musculoskelet Disord       Date:  2012-02-20       Impact factor: 2.362

Review 2.  Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.

Authors:  Ron Dabby
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.

Authors:  Michael Costigan; Inna Belfer; Robert S Griffin; Feng Dai; Lee B Barrett; Giovanni Coppola; Tianxia Wu; Carly Kiselycznyk; Minakshi Poddar; Yan Lu; Luda Diatchenko; Shad Smith; Enrique J Cobos; Dmitri Zaykin; Andrew Allchorne; Edith Gershon; Jessica Livneh; Pei-Hong Shen; Lone Nikolajsen; Jaro Karppinen; Minna Männikkö; Anthi Kelempisioti; David Goldman; William Maixner; Daniel H Geschwind; Mitchell B Max; Ze'ev Seltzer; Clifford J Woolf
Journal:  Brain       Date:  2010-08-18       Impact factor: 13.501

Review 4.  [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].

Authors:  K Doppler; C Sommer
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

5.  Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNav1.7.

Authors:  Robert A Neff; Mack Flinspach; Alan Gibbs; Amy Y Shih; Natali A Minassian; Yi Liu; Ross Fellows; Ondrej Libiger; Stephanie Young; Michael W Pennington; Michael J Hunter; Alan D Wickenden
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

Review 6.  Recent advances in the understanding of genetic susceptibility to chronic pain and somatic symptoms.

Authors:  Kate L Holliday; John McBeth
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

7.  [Pain and analgesia : Mutations of voltage-gated sodium channels].

Authors:  M J Eberhardt; A Leffler
Journal:  Schmerz       Date:  2017-02       Impact factor: 1.107

Review 8.  Regulating excitability of peripheral afferents: emerging ion channel targets.

Authors:  Stephen G Waxman; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

Review 9.  Genetic variability of pain perception and treatment--clinical pharmacological implications.

Authors:  Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2011-02-23       Impact factor: 2.953

10.  Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.

Authors:  Jonathan Nissenbaum; Marshall Devor; Ze'ev Seltzer; Mathias Gebauer; Martin Michaelis; Michael Tal; Ruslan Dorfman; Merav Abitbul-Yarkoni; Yan Lu; Tina Elahipanah; Sonia delCanho; Anne Minert; Kaj Fried; Anna-Karin Persson; Hagai Shpigler; Erez Shabo; Benjamin Yakir; Anne Pisanté; Ariel Darvasi
Journal:  Genome Res       Date:  2010-08-05       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.